These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 30413749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. N-methylisatin-beta-thiosemicarbazone derivative (SCH 16) is an inhibitor of Japanese encephalitis virus infection in vitro and in vivo.
    Sebastian L, Desai A, Shampur MN, Perumal Y, Sriram D, Vasanthapuram R.
    Virol J; 2008 May 22; 5():64. PubMed ID: 18498627
    [Abstract] [Full Text] [Related]

  • 5. Molecular interaction of the antiviral compound CW‑33 and its analogues with the NS2B‑NS3 protease of the Japanese encephalitis virus.
    Chen KC, Lin YF, Huang AC, Gao JY, Lin CW, Lien JC.
    Int J Mol Med; 2019 May 22; 43(5):2024-2032. PubMed ID: 30816489
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epigallocatechin-3-gallate inhibits the early stages of Japanese encephalitis virus infection.
    Wang CY, Hour MJ, Lai HC, Chen CH, Chang PJ, Huang SH, Lin CW.
    Virus Res; 2018 Jul 15; 253():140-146. PubMed ID: 29958923
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.
    Chen L, Liu Y, Wang S, Sun J, Wang P, Xin Q, Zhang L, Xiao G, Wang W.
    Antiviral Res; 2017 May 15; 141():140-149. PubMed ID: 28232248
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo.
    Wei J, Hameed M, Wang X, Zhang J, Guo S, Anwar MN, Pang L, Liu K, Li B, Shao D, Qiu Y, Zhong D, Zhou B, Ma Z.
    Antiviral Res; 2020 Feb 15; 174():104673. PubMed ID: 31812636
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Two novel compounds inhibit Flavivirus infection in vitro and in vivo by targeting lipid metabolism.
    Zhou J-f, Zhang M-r, Wang Q, Li M-z, Bai J-s, Dai Q, Zhang Y-h, Yan M-x, Li X-h, Chen J, Liu Y-y, Liu C-c, Ye J, Zhou B.
    J Virol; 2024 Sep 17; 98(9):e0063524. PubMed ID: 39158346
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model.
    Shi Z, Wei J, Deng X, Li S, Qiu Y, Shao D, Li B, Zhang K, Xue F, Wang X, Ma Z.
    Virol J; 2014 Jan 23; 11():10. PubMed ID: 24456815
    [Abstract] [Full Text] [Related]

  • 17. Antiviral and anti-inflammatory activity of novel belladonna formulation against Japanese encephalitis virus via inhibition of p65 nuclear translocation and TNF-α mediated NF-kB signaling.
    Saxena SK, Kumar S, Maurya VK, Nayak D, Kaushik S, Manchanda RK, Gadugu S.
    Biotechnol Genet Eng Rev; 2023 Oct 23; 39(2):937-959. PubMed ID: 36718919
    [Abstract] [Full Text] [Related]

  • 18. In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation.
    Pang R, He DN, Zhou B, Liu K, Zhao J, Zhang XM, Chen PY.
    Antiviral Res; 2013 Mar 23; 97(3):369-75. PubMed ID: 23321201
    [Abstract] [Full Text] [Related]

  • 19. Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus.
    Lu CY, Hour MJ, Wang CY, Huang SH, Mu WX, Chang YC, Lin CW.
    Viruses; 2017 Apr 10; 9(4):. PubMed ID: 28394283
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5.
    Huang HN, Rajanbabu V, Pan CY, Chan YL, Hui CF, Chen JY, Wu CJ.
    Biomaterials; 2011 Oct 10; 32(28):6804-14. PubMed ID: 21726898
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.